These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 10221213
1. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Lin Y, Kahn JA, Hillensjö T. Hum Reprod; 1999 Apr; 14(4):885-8. PubMed ID: 10221213 [Abstract] [Full Text] [Related]
7. Gonadotropin-releasing hormone analogs inhibit primate granulosa cell steroidogenesis via a mechanism distinct from that in the rat. Wickings EJ, Eidne KA, Dixson AF, Hillier SG. Biol Reprod; 1990 Aug; 43(2):305-11. PubMed ID: 2165826 [Abstract] [Full Text] [Related]
8. Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro. Mitwally MF, Casper RF. J Assist Reprod Genet; 2002 Aug; 19(8):384-9. PubMed ID: 12182445 [Abstract] [Full Text] [Related]
11. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH. Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553 [Abstract] [Full Text] [Related]
13. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, Van Steirteghem AC. Hum Reprod; 1992 Oct; 7(9):1225-9. PubMed ID: 1479002 [Abstract] [Full Text] [Related]
14. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells. Miller I, Chuderland D, Ron-El R, Shalgi R, Ben-Ami I. J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290 [Abstract] [Full Text] [Related]
15. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. Albano C, Smitz J, Tournaye H, Riethmüller-Winzen H, Van Steirteghem A, Devroey P. Hum Reprod; 1999 Jun; 14(6):1426-30. PubMed ID: 10357952 [Abstract] [Full Text] [Related]
16. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model. Roth C, Leonhardt S, Seidel C, Luft H, Wuttke W, Jarry H. Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237 [Abstract] [Full Text] [Related]
17. Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective, randomized in-vitro fertilization study. Dor J, Bider D, Shulman A, Levron JL, Shine S, Mashiach S, Rabinovici J. Hum Reprod; 2000 Jun; 15(6):1225-30. PubMed ID: 10831545 [Abstract] [Full Text] [Related]
18. Effect of gonadotrophin-releasing hormone and related analogue on human luteal cell function in vitro. Lanzone A, Panetta V, Di Simone N, Arno E, Fulghesu AM, Caruso A, Mancuso S. Hum Reprod; 1989 Nov; 4(8):906-9. PubMed ID: 2559106 [Abstract] [Full Text] [Related]
19. Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists. Ortmann O, Weiss JM, Diedrich K. Hum Reprod; 2001 Apr; 16(4):608-11. PubMed ID: 11278203 [Abstract] [Full Text] [Related]